The purpose of this study is to determine whether continuous glucose monitoring will improve glucose variability as measured by the coefficient of variation of glucose levels in very young children with T1D. The study adopts an open-label, multi-centre, multinational, prospective registry-based population cohort design contrasting CGM use to SMBG alone in young children with type 1 diabetes over 12 months. The primary endpoint is the difference between treatment modalities (CGM vs SMBG alone) in glycaemic variability, measured as the coefficient of variation of glucose levels, during the 12 months observational period. Other Key edpoints include time in range 70-180 mg/dl, time below range 70 mg/dl and time above range 180 mg/dl.
Study Type
OBSERVATIONAL
Enrollment
339
Medical Faculty - University of Ljubljana
Ljubljana, Slovenia
Coefficient of variation
Time frame: 1 year
Time in Range
Time in Range 70 - 180 mg/dl
Time frame: 1 year
Time Above Range
Time in Range above 180 mg/dl
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.